PRADEYROL DEVELOPMENT
Pradeyrol Development is a family office that invests in firms with great innovative potential, especially in the biotechnology sector where it aims at taking significant minority shares. Pradeyrol Dรฉveloppement entrusted Alexandre Le Vert (the CEO of Imaxio) with the task of broadening its Biotechnology portfolio by investing in companies mostly positioned in Immunology or Personalized Diagnostics and with respected management.
Similar Organizations
Commercial Development Bank
Commercial Development Bank is a banking firm that provides financial services.
Lind Invest
Lind Invest is a single-family office and long-term investor.
Turkey Development Fund
Turkey Development Fund aims to develop the enterprise ecosystem by investing in new generation startups.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2014-03-26 | Hybrigenics | Pradeyrol Development investment in Post-IPO Equity - Hybrigenics | 6.1 M EUR |
2013-10-16 | Hybrigenics | Pradeyrol Development investment in Post-IPO Equity - Hybrigenics | 1.3 M EUR |
More informations about "Pradeyrol Development"
Pradeyrol Development (PRD) - life-sciences-europe.com
Jan 1, 2007 Organisation โบ Details Pradeyrol Development (PRD) Pradeyrol Development is a family office that invests in firms with great innovative potential, especially in the biotechnology โฆSee details»
Pradeyrol Development - Investments, Portfolio & Company Exits
Pradeyrol Development has had . obfuscated. obfuscated. exit, which was Hybrigenics. Which industries has this organization had the most exits in? Show . Hybrigenics Hybrigenics offers a โฆSee details»
Pradeyrol Développement Investor Profile | Preqin
Pradeyrol Développement is a corporate investor that invests in firms with innovative potential, especially in the biotechnology sector, focusing mainly on v... Disallowed. Yes No. Products. โฆSee details»
Pradeyrol Développement Company Profile, Financial and
Pradeyrol Développement owns and operates a group of private clinics. The company was incorporated in 2007 and is based in Paris, France. digitGaps report on Pradeyrol โฆSee details»
PRADEYROL DEVELOPPEMENT - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PRADEYROL DEVELOPPEMENT of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & โฆSee details»
Dr Christian Pradeyrol, MD - Osivax
Dr PRADEYROL is the Executive Chairman and Founder of Pradeyrol Développement, a family office actively investing in new technologies. With participations in a dozen of Biotech โฆSee details»
Pradeyrol Recherche-Developpement - CB Insights
Jun 14, 2017 Pradeyrol Recherche-Developpement is a family fund which invests in firms with considerable potential for innovation, particularly in the biotechnology sector (focusing mainly โฆSee details»
Pradeyrol Development (PRD) - life-sciences-europe.com
Upcoming Events. ChinaBio Partnering Forum 2023 Shanghai; BioSpain 2023 Barcelona; ILMAC 2023 Basel; BioCap Conference 2023 Alderley Park; BIO-Europe 2023 München (Munich)See details»
Pradeyrol Development โ 2 Investments, Portfolio, Team โฆ
Pradeyrol Development. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom โฆSee details»
Christian Pradeyrol - Crunchbase Person Profile
Dr. Christian PRADEYROL is Chairman of the Board of IMAXIO and CEO. Since 2007, Dr. PRADEYROL is Executive Chairman and founder of Pradeyrol Développement, a family office โฆSee details»
Organisation > Details [LSE] Life-Sciences-Europe.com - The โฆ
Upcoming Events. J.P. Morgan 42nd Annual Healthcare Conference 2024 San Francisco; BIO 2024 San Diego (BIO International Convention) Enmore Bio China 2024 Suzhou (EBC 2024)See details»
Pradeyrol Developpement - BioCentury Company Profiles - BCIQ
Apr 7, 2014 Pradeyrol Developpement - BioCentury Company Profiles for the biopharma industrySee details»
Imaxio Closes EUR 2.9 Million Funding Round - Technology โฆ
Apr 18, 2012 Funding will enable the clinical development of its IMX313 carrier protein platform for vaccines, and update the marketing authorization application it filed in France.See details»
Learning and Development Trends for 2025: Shaping the Future of ...
Organizations will also prioritize diversity and inclusion in leadership pipelines, ensuring representation and equity. Why It Matters: Investing in leadership development strengthens โฆSee details»
The Pan African Farmersโ Organization (PAFO) and African โฆ
17 hours ago The meeting culminated in plans to jointly host a High-Level Conference on Financing Small-Scale Farmers in the second quarter of 2025. ABIDJAN, Ivory Coast, โฆSee details»
Decades of Change: A Short History of International Development ...
In contrast to this global reputation, international development organizations are among the types of charities that Canadians trust the least, and this trust has declined since 2006 (Lasby & โฆSee details»
Post-IPO Equity - Hybrigenics - 2013-10-16 - Crunchbase
Hybrigenics raised $1758453 on 2013-10-16 in Post-IPO Equity. Start Free TrialSee details»
Nak'azdli Development Corporation | Home
Discover the Nak'azdli Development Corporation, an innovative organization dedicated to economic reconciliation and community empowerment for the Nak'azdli Whutโen. Explore our โฆSee details»
LENDEV LAB - Home
The Land, Environment and Development lab, led by Yann le Polain de Waroux, is part of the Institute for the Study of International Development and the Department of Geography at โฆSee details»
How Kyndrylโs CHRO led a corporate cultural transformation post โฆ
13 hours ago After technology services company Kyndryl separated from IBM, Maryjo Charbonnier was tasked with structuring a whole new organization for 80,000 workers. HR โฆSee details»